Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Geld Baltic, operating under the brand Super Garden, is a Lithuanian life sciences and food technology company specializing in advanced freeze-drying (lyophilization) solutions. The company focuses on the development and production of functional foods, preserving the biological value and nutritional integrity of raw materials through its proprietary "Bites" technology. This patented process enables the creation of nutrient-dense, additive-free snacks and supplements by combining various powders into lyophilized forms. Geld Baltic actively collaborates with scientific institutions to innovate in the field of personalized nutrition and high-value food processing. Their products are distributed globally, catering to the health-conscious consumer and B2B sectors. The company's manufacturing facility is equipped for large-scale lyophilization, supporting both internal brands and contract manufacturing requirements.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Geld Baltic.